BIOMARKER:

ATR mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

ATR mutation	Solid Tumor	ATR mutation	Solid Tumor	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
ATR mutation	Gastroesophageal Junction Adenocarcinoma	ATR mutation	Gastroesophageal Junction Adenocarcinoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
ATR mutation	Gastric Adenocarcinoma	ATR mutation	Gastric Adenocarcinoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
ATR mutation	Colon Cancer	ATR mutation	Colon Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
ATR mutation	HER2 Negative Breast Cancer	ATR mutation	HER2 Negative Breast Cancer	talazoparib Sensitive: C3 – Early Trials talazoparib Sensitive : C3	talazoparib Sensitive: C3 – Early Trials talazoparib Sensitive : C3
ATR mutation	Colorectal Cancer	ATR mutation	Colorectal Cancer	M6620 + SNB-101 Sensitive: D – Preclinical M6620 + SNB-101 Sensitive : D	M6620 + SNB-101 Sensitive: D – Preclinical M6620 + SNB-101 Sensitive : D
ATR mutation	Colorectal Cancer	ATR mutation	Colorectal Cancer	M6620 Sensitive: D – Preclinical M6620 Sensitive : D	M6620 Sensitive: D – Preclinical M6620 Sensitive : D
ATR mutation	Colorectal Cancer	ATR mutation	Colorectal Cancer	SNB-101 Sensitive: D – Preclinical SNB-101 Sensitive : D	SNB-101 Sensitive: D – Preclinical SNB-101 Sensitive : D